New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.
|Slideshows|June 17, 2015
10 FDA-Approved Drugs for Primary Care
Author(s)Grace Halsey
Since January 2015, the FDA has approved more than a dozen drugs indicated for primary care diseases. Here, a quick slide update on 10 of them.
Advertisement
Since January 2015, the FDA has approved more than a dozen medications indicated for primary care diseases. In the slides above, a brief look at 10 of the newest approvals, starting with the most recent.
Advertisement
Related to this article
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
The FDA accepted Organon’s MIUDELLA supplemental application, but the proposed change, supporting data, and review timeline remain undisclosed.
Axsome has launched the SUMMIT phase 3 clinical trial evaluating AXS-05 to help adults quit smoking, comparing it with bupropion and placebo over 12 weeks.
A new scientific statement calls for a shift in obesity management and treatment to focus on overall health improvements rather than just weight loss alone.
New research underscores the need for public health interventions to improve the microbial and fiber content of diets in the US.
FDA awarded DT120 Breakthrough Therapy designation for MDD based on phase 3 data showing rapid, sustained improvement after one 100 μg dose.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Elevated PSA in Primary Care: What to Consider Before Biopsy
3
FDA Grants Priority Review to Zasocitinib for Plaque Psoriasis
4
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
5